TrialClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2020

A phase 2 study to evaluate the safety, efficacy and pharmacokinetics of DP2 antagonist GB001 and to explore biomarkers of airway inflammation in mild-to-moderate asthma.

Hector Ortega et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.